SCHEMBL6506657

SCHEMBL6506657

COc1cc(/C=C/C(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)c([N+](=O)[O-])cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.53
OPRK1 P41145 1/20 0.53
POLB P06746 1/20 0.45
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
APOBEC3A P31941 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
ITGAL P20701 3/20 0.41
ITGB2 P05107 2/20 0.41
ICAM1 P05362 2/20 0.41
KDM4E B2RXH2 3/20 0.41
EPHX2 P34913 1/20 0.41
ABCB1 P08183 1/20 0.40
CAPN1 P07384 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6506666 1.00 OPRM1 (0.53) OPRM1OPRK1POLBNPC1RAB9A
SCHEMBL6505746 0.85 NPC1 (0.44) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6505741 0.85 NPC1 (0.44) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6506032 0.84 POLB (0.49) POLBNPC1RAB9AITGALITGB2
SCHEMBL6506038 0.84 POLB (0.49) POLBNPC1RAB9AITGALITGB2
SCHEMBL6504799 0.80 SMN1; SMN2 (0.51) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6504800 0.80 SMN1; SMN2 (0.51) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6496828 0.79 KDM4E (0.48) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6502814 0.79 NPC1 (0.46) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL
SCHEMBL6496819 0.79 KDM4E (0.48) NPC1RAB9AAPOBEC3AAPOBEC3GITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed